Category: Amplification Technologies

Amplification Technologies

The funding will support commercialization of the company's extracellular vesicle-based liquid biopsy tests, starting with ovarian cancer screening.

Research shows that cell-free DNA in cerebrospinal fluid can be used to identify patients at risk of pediatric medulloblastoma relapse.